Clustering and erratic movement patterns of syringe-injected versus mosquito-inoculated malaria sporozoites underlie decreased infectivity

• Published in: bioRxiv
• Main Authors: De Korne, Cm, Winkel, Bmf, Mn Van Oosterom, Chevalley-Maurel, S, Houwing, Hm, Sijtsma, Jc, Baalbergen, E, Franke-Fayard, Bmd, Fwb Van Leeuwen, Roestenberg, M
• Format: Paper
• Language: English
• Published: Cold Spring Harbor Cold Spring Harbor Laboratory Press 21.10.2020
• Subjects: Infectivity; Inoculation; Liver; Malaria; Mosquitoes; Sporozoites; Vaccines
• DOI: 10.1101/2020.10.21.348573

ABSTRACT Live attenuated malaria sporozoites are promising vaccine candidates, however, their efficacy critically depends on their capability to reach and infect the host liver. Administration via mosquito inoculation is by far the most potent method for inducing immunity, but highly unpractical. Here, we observed that intradermal syringe-injected Plasmodium berghei sporozoites (syrSPZ) were three-fold less efficient in migrating to and infecting mouse liver compared to mosquito-inoculated sporozoites (msqSPZ). This was related to a clustered dermal distribution (2-fold decreased median distance between syrSPZ vs msqSPZ) and, more importantly, a 1.4-fold significantly slower and more erratic movement pattern. These erratic movement patterns were likely caused by alteration of dermal tissue morphology (>15 μm intercellular gaps) due to injection pressure and may critically decrease sporozoite infectivity. These results suggest that novel microvolume-based administration technologies hold promise for replicating the success of mosquito-inoculated live attenuated sporozoite vaccines. Competing Interest Statement The authors have declared no competing interest.